,88 Finally, sEH inhibition does not modify insulin sensitivity in patients with obesity and prediabetes89 and loss of EPHX1 activity causes lipoatrophic diabetes syndrome.90 Here, EPHX1 is linked to obesity due to melanocortin 4 receptor deficiency.